Cellmates On The Run Foundation
- Assets
- $3.6m
- Revenue
- $1.2m
- Investments
- $0.0
- Employees
- 5
- Location
- Chicago, IL
- Founding
- 02/2017
- Data as of
- 12/2022
- EIN
- 81-4181048
Organization Overview
Cellmates On The Run Foundation, operating under the name Chicago Diabetes Project, is located in Chicago, IL. The organization was established in 2017. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 12/2022, Chicago Diabetes Project employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Chicago Diabetes Project is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Chicago Diabetes Project generated $1.2m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 5 years, the organization has seen revenues fall by an average of (4.7%) each year. All expenses for the organization totaled $336.2k during the year ending 12/2022. As we would expect to see with falling revenues, expenses have declined by (9.3%) per year over the past 5 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
SUPPORT A GLOBAL COLLABORATION OF RESEARCH SCIENTISTS TO FUNCTIONALLY CURE DIABETES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
SUPPORT RESEARCH SCIENTISTS AND PHYSICIANS TO FUNCTIONALLY CURE DIABETES THROUGH ISLET CELL TRANSPLANTATION. THREE GOALS ARE PURSUED. FIRST, SEEK FDA APPROVAL OF ISLET CELL TRANSPLANTATION WITH SYSTEMIC IMMUNOSUPPRESSION TO TREAT BRITTLE TYPE I DIABETIC PATIENTS. SECOND,DEVELOP A WAY TO SAFELY ENCAPSULATE ISLETS SO THAT NO LONG-TERM IMMUNOSUPPRESION IS NEEDED. THIRD, DEVELOP TECHNOLOGY TO REPRODUCE HUMAN ISLETS TO HAVE AN UNLIMITED SOURCE OF GLUCOSE RESPONSIVE INSULIN SECRETING CELLS. IN ADDITION, THE FOUNDATION RAISES AWARENESS OF TYPE I DIABETES THROUGH EVENTS AND ASSISTS IN THE PURCHASE OF RESEARCH EQUIPMENT
GRANTS TO RELATED RESEARCH GROUPS IN THE USA
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Jill Dine Executive Director | OfficerTrustee | 2 | $25,000 |
Amy Cogswell Director | Trustee | 2 | $0 |
John Dine Director | Trustee | 2 | $0 |
Brigitte Oberholzer Director | Trustee | 2 | $0 |
Jennifer Cook Director - Treasurer | OfficerTrustee | 2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $1,092,260 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $1,092,260 |
| Total Program Service Revenue | $0 |
| Investment income | $41,026 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $116,418 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,249,704 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $210,352 |
| Grants and other assistance to domestic individuals. | $35 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $71,797 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $348 |
| Fees for services: Legal | $895 |
| Fees for services: Accounting | $10,719 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $7,832 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $12,875 |
| Travel | $5,101 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $8,334 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $0 |
| Total functional expenses | $336,162 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $1,505,027 |
| Savings and temporary cash investments | $107,907 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $1,957,000 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $24,236 |
| Total assets | $3,594,170 |
| Accounts payable and accrued expenses | $2,840 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $2,840 |
| Net assets without donor restrictions | $3,591,330 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $3,594,170 |
Grants Awarded
Over the last fiscal year, Cellmates On The Run Foundation has awarded $141,053 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
GIFT OF HOPE ORGAN & TISSUE NETWORK | | | $4,060 |
UNIVERSITY OF ILLINOIS | | | $65,811 |
NORWEGIAN UNIVOF SCIENCE & TECH | | | $71,182 |